Keyword: Active Pharmaceutical Ingredients (APIs)

Markets & Companies

Opportunities and Limits of Sustainability

07.06.2023 -

The Pharmaceutical industry must prioritize sustainability. Jürgen Roos, Chief Scientific Officer (CSO) of Siegfried, explains opportunities and limits of sustainability...

Markets & Companies

Special Issue: Swiss CDMO Siegfried Celebrates 150th Anniversary

07.06.2023 -

There are only a few chemical and pharmaceutical companies that look back at a history of 150 years. Certainly, many companies claim such a long legacy, but if you only...

News

Olon Expands API Production

26.05.2023 -

Olon, an Italian CDMO and API producer, is investing a total of €100 million in 2023 to increase production capacity, in particular at its site in Mulazzano, Lodi...

News

Wacker Buys All of ADL BioPharma from Private Equity

11.05.2023 -

German chemical group Wacker has acquired 100% of ADL Biopharma from private equity investor Kartesia for a price said to exceed €100 million. It now owns the entire 150...

News

IMCD Seals Two Acquisitions and a Distribution Deal

09.05.2023 -

Rotterdam-based speciality chemicals distributor IMCD kicked off the month of May agreeing a major distribution partnership and two outright acquisitions.

News

Glenmark Putting Chunk of API Offshoot up for Sale?

02.05.2023 -

India-headquartered drugmaker Glenmark is said to be taking another look at selling a majority stake in its business with active pharmaceutical ingredients (APIs), which...

Strategy & Management

Containment Solutions for HPAPI Manufacturing

21.03.2023 -

Clear incentive for drug manufacturers to equip their production facilities with the capacity to process highly potent active pharmaceutical ingredients (HPAPIs). HPAPIs...

News

US Uncovers Covid-related Bogus API-making Deals

03.03.2023 -

Under US president Joe Biden, the Department of Justice has been moving energetically of late to uncover and prosecute offenses that might otherwise have been swept under...